CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease - Kouki,T.; Sawai,Y.; Gardine,C.A. (J Immunol, 2000)